TWO SIGMA SECURITIES, LLC

Broker-Dealer

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1450144 NEW YORK, NY

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$49,508

+$17,292 QoQ

Shares Held

37,793

+85.4% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#59

of 130 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA SECURITIES, LLC holds $22,805,438 across 104 Biotechnology names. LCTX ranks #54 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	5,761	$3,592,213
2	ALNY	Alnylam Pharmaceuticals, Inc.	5,585	$1,681,252
3	BBIO	BridgeBio Pharma, Inc.	17,689	$1,317,476
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,219	$1,191,492
5	INSM	INSMED Inc	10,338	$1,102,237
6	HALO	Halozyme Therapeutics, Inc.	12,525	$980,331
7	ARWR	Arrowhead Pharmaceuticals, Inc.	11,256	$917,476
8	AXSM	Axsome Therapeutics, Inc.	3,708	$907,607

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,508	37,793	+85.4%	Shares	Sole	2026-08-14
2026-03-31	$32,216	20,390	-13.6%	Shares	Sole	2026-05-15
2025-12-31	$39,408	23,598	+30.9%	Shares	Sole	2026-02-17
2025-06-30	$16,405	18,028	+29.3%	Shares	Sole	2025-08-14
2024-09-30	$12,686	13,941	+9.7%	Shares	Sole	2024-11-14
2023-12-31	$13,847	12,704	-23.2%	Shares	Sole	2024-02-14
2023-03-31	$24,807	16,538	-4.5%	Shares	Sole	2023-05-15
2022-12-31	$20,264	17,320	-82.1%	Shares	Sole	2023-02-14
2021-09-30	$243,840	96,762	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.